Integrating Smoking Cessation With Low-dose CT-screening for Lung Cancer
Recruiting · NCT07331519 · Interventional (participants receive a specific treatment) · Lead sponsor: Oulu University Hospital
View the official record on ClinicalTrials.gov →Interventions studied
Smartphone applicationWritten materials for smoking cessationlow-dose computed tomography
What this trial is about
The study investigates effectiveness of different smoking cessation methods and low-dose CT based lung cancer screening
Who can take part
Age range
50 Years to 74 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Able to provide written informed consent
- Age between 50-74
- Smoked ≥ 15 cigarettes/day for ≥ 25 years or smoked ≥ 10 cigarettes/day for ≥ 30 years and are active smokers (smoking during the last two weeks)
- Access to a smartphone (iPhone or Android)
Exclusion criteria
- Current or past melanoma, lung, renal or breast cancer
- A chest CT examination less than one year before inclusion
- Has known psychiatric or substance abuse disorders that would interfere with cooperation with the requirements of the trial
- No access to a smartphone (iPhone or Android)
- Participant is unwilling or unable to comply with treatment and trial instructions
- Any condition that study investigators consider an impediment to safe trial participation
Where it is running
5 locations listed.
- Helsinki University Hospital - Helsinki, Finland
- Oulu University Hospital - Oulu, Finland
- Tampere University Hospital - Tampere, Finland
- Turku University Hospital - Turku, Finland
- Vaasa Central Hospital - Vaasa, Finland